Literature DB >> 12443887

Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor.

Michele Magni1, Massimo Di Nicola, Carmelo Carlo-Stella, Paola Matteucci, Cristiana Lavazza, Salvatore Grisanti, Carlo Bifulco, Silvana Pilotti, Daniela Papini, Juan Rosai, Alessandro M Gianni.   

Abstract

Mesh:

Year:  2002        PMID: 12443887     DOI: 10.1016/s0145-2126(02)00009-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  11 in total

1.  Expression of CD56 antigen in Langerhans cell histiocytosis associated with T-lymphoblastic lymphoma in a same lymph node.

Authors:  Young-Hyeh Ko; Won-Seog Kim; Yoonjung Kim
Journal:  Virchows Arch       Date:  2005-10-14       Impact factor: 4.064

Review 2.  Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Authors:  Jean-François Emile; Oussama Abla; Sylvie Fraitag; Annacarin Horne; Julien Haroche; Jean Donadieu; Luis Requena-Caballero; Michael B Jordan; Omar Abdel-Wahab; Carl E Allen; Frédéric Charlotte; Eli L Diamond; R Maarten Egeler; Alain Fischer; Juana Gil Herrera; Jan-Inge Henter; Filip Janku; Miriam Merad; Jennifer Picarsic; Carlos Rodriguez-Galindo; Barret J Rollins; Abdellatif Tazi; Robert Vassallo; Lawrence M Weiss
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

3.  Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry.

Authors:  Ichiro Murakami; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Kazuhiko Hayashi; Jean Gogusev; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2011-05-22       Impact factor: 4.064

4.  The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.

Authors:  David M Dorfman; Jason L Hornick; Aliakbar Shahsafaei; Gordon J Freeman
Journal:  Hum Pathol       Date:  2010-07-24       Impact factor: 3.466

5.  Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity.

Authors:  Maria Raffaella Ambrosio; Giulia De Falco; Bruno Jim Rocca; Aurora Barone; Teresa Amato; Cristiana Bellan; Stefano Lazzi; Lorenzo Leoncini
Journal:  Virchows Arch       Date:  2015-08-19       Impact factor: 4.064

6.  Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone.

Authors:  Andrew L Feldman; Daniel A Arber; Stefania Pittaluga; Antonio Martinez; Jerome S Burke; Mark Raffeld; Mireia Camos; Roger Warnke; Elaine S Jaffe
Journal:  Blood       Date:  2008-02-13       Impact factor: 22.113

Review 7.  Histiocytic/dendritic cell sarcoma arising from follicular lymphoma involving the bone: a case report and review of literature.

Authors:  Da Zhang; Joseph McGuirk; Siddhartha Ganguly; Diane L Persons
Journal:  Int J Hematol       Date:  2009-04-03       Impact factor: 2.490

Review 8.  Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.

Authors:  Ichiro Murakami; Michiko Matsushita; Takeshi Iwasaki; Satoshi Kuwamoto; Masako Kato; Keiko Nagata; Yasushi Horie; Kazuhiko Hayashi; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Jean Gogusev; Francis Jaubert; Katsuyoshi Takata; Takashi Oka; Tadashi Yoshino
Journal:  Cell Commun Signal       Date:  2015-02-22       Impact factor: 5.712

Review 9.  Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.

Authors:  Caroline Hutter; Milen Minkov
Journal:  Immunotargets Ther       Date:  2016-10-12

10.  High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.

Authors:  Wenting Huang; Tian Qiu; Linshu Zeng; Bo Zheng; Jianming Ying; Xiaoli Feng
Journal:  Oncotarget       Date:  2016-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.